RA Rudick

530 total citations
10 papers, 314 citations indexed

About

RA Rudick is a scholar working on Pathology and Forensic Medicine, Oncology and Rheumatology. According to data from OpenAlex, RA Rudick has authored 10 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 4 papers in Oncology and 4 papers in Rheumatology. Recurrent topics in RA Rudick's work include Multiple Sclerosis Research Studies (9 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Peripheral Neuropathies and Disorders (3 papers). RA Rudick is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Peripheral Neuropathies and Disorders (3 papers). RA Rudick collaborates with scholars based in United States, Netherlands and Ireland. RA Rudick's co-authors include Nicholas G. LaRocca, Daniel Ontaneda, Timothy Coetzee, Dennis Bourdette, Pamela Foulds, Bianca Weinstock‐Guttman, Jill S. Fischer, Marie Namey, CH Polman and Frances Lynn and has published in prestigious journals such as American Journal of Ophthalmology, Multiple Sclerosis Journal and Journal of Clinical Psychopharmacology.

In The Last Decade

RA Rudick

10 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
RA Rudick United States 8 278 124 113 55 25 10 314
M.C. Edo Spain 8 262 0.9× 81 0.7× 96 0.8× 63 1.1× 50 2.0× 10 334
Breogán Rodrı́guez‐Acevedo Spain 9 303 1.1× 102 0.8× 143 1.3× 54 1.0× 34 1.4× 18 346
Laura Willis United States 7 305 1.1× 79 0.6× 86 0.8× 52 0.9× 60 2.4× 9 376
Elisabetta Verdun di Cantogno United States 11 380 1.4× 98 0.8× 139 1.2× 93 1.7× 36 1.4× 23 437
Fabio Brusaferri Italy 4 298 1.1× 71 0.6× 193 1.7× 53 1.0× 25 1.0× 5 370
Alessandra Murialdo Italy 9 259 0.9× 53 0.4× 113 1.0× 92 1.7× 45 1.8× 12 383
N. P. Robertson United Kingdom 7 250 0.9× 105 0.8× 84 0.7× 46 0.8× 24 1.0× 18 368
Virginia Devonshire Canada 8 463 1.7× 155 1.3× 196 1.7× 77 1.4× 50 2.0× 11 551
J Richert United States 4 445 1.6× 167 1.3× 263 2.3× 61 1.1× 69 2.8× 5 515
Jimena Míguez Argentina 11 220 0.8× 57 0.5× 85 0.8× 25 0.5× 29 1.2× 19 252

Countries citing papers authored by RA Rudick

Since Specialization
Citations

This map shows the geographic impact of RA Rudick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RA Rudick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RA Rudick more than expected).

Fields of papers citing papers by RA Rudick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RA Rudick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RA Rudick. The network helps show where RA Rudick may publish in the future.

Co-authorship network of co-authors of RA Rudick

This figure shows the co-authorship network connecting the top 25 collaborators of RA Rudick. A scholar is included among the top collaborators of RA Rudick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RA Rudick. RA Rudick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Fisher, Elizabeth, Kunio Nakamura, JC Lee, et al.. (2015). Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing−remitting multiple sclerosis: A retrospective analysis. Multiple Sclerosis Journal. 22(5). 668–676. 23 indexed citations
2.
Ontaneda, Daniel, Nicholas G. LaRocca, Timothy Coetzee, & RA Rudick. (2012). Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures. Multiple Sclerosis Journal. 18(8). 1074–1080. 58 indexed citations
3.
Weinstock‐Guttman, Bianca, et al.. (2010). Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study. Multiple Sclerosis Journal. 16(5). 588–596. 60 indexed citations
4.
Rudick, RA, Ludwig Kappos, R. Philip Kinkel, et al.. (2010). Gender effects on intramuscular interferon beta-1a in relapsing–remitting multiple sclerosis: analysis of 1406 patients. Multiple Sclerosis Journal. 17(3). 353–360. 18 indexed citations
5.
Rudick, RA, CH Polman, JA Cohen, et al.. (2009). Assessing disability progression with the Multiple Sclerosis Functional Composite. Multiple Sclerosis Journal. 15(8). 984–997. 75 indexed citations
6.
Fisher, Elizabeth, Eva Havrdová, Michael Hutchinson, et al.. (2006). The effects of natalizumab on brain atrophy and cognitive function: results from the AFFIRM study. 1 indexed citations
7.
Richert, J, et al.. (1999). Results of an Ongoing, Open-Label, Safety-Extension Study of Interferon Beta-1a (Avonex) Treatment in Multiple Sclerosis. International Journal of MS Care. 1(2). 3–11. 21 indexed citations
8.
Rudick, RA, et al.. (1996). Cerebrospinal fluid in acute optic neuritis: Experience of the Optic Neuritis Treatment Trial. American Journal of Ophthalmology. 122(1). 144–145. 5 indexed citations
9.
Rudick, RA, et al.. (1995). Multiple sclerosis progression in a natural history study: Predictive value of cerebrospinal fluid free kappa light chains. Multiple Sclerosis Journal. 1(3). 150–155. 42 indexed citations
10.
Rudick, RA, et al.. (1985). Treatment of pathologic laughing and weeping with amitriptyline. Journal of Clinical Psychopharmacology. 5(5). 308–308. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.C. Edo Breakdown of academic impact, for papers by Breogán Rodrı́guez‐Acevedo Breakdown of academic impact, for papers by Laura Willis Breakdown of academic impact, for papers by Elisabetta Verdun di Cantogno Breakdown of academic impact, for papers by Fabio Brusaferri Breakdown of academic impact, for papers by Alessandra Murialdo Breakdown of academic impact, for papers by N. P. Robertson Breakdown of academic impact, for papers by Virginia Devonshire Breakdown of academic impact, for papers by J Richert Breakdown of academic impact, for papers by Jimena Míguez
Rankless by CCL
2026